NADIINovartis Agricultural Discovery Institute, Inc
References in periodicals archive ?
Under terms of the agreement, NADII will fund the development of a proprietary product addressing nutraceutical, cosmeceutical, and pharmaceutical markets, to be developed using SemBioSys' proprietary oleosin system.
amp;uot;The agreement with NADII is a further validation of the utility of our technology&uot; said Andrew Baum, SemBioSys' President and Chief Executive Officer.
NADII is funded by the Novartis Research Foundation, an independent research foundation that was established and funded by Novartis.